Vireo Growth (VREOF) Other Non-Current Assets (2020 - 2026)

Vireo Growth's (VREOF) quarterly Other Non-Current Assets came in at $4.4 million in Q1 2026, up 944.53% year-on-year from $421244.0 in Q1 2025, and little changed quarter-over-quarter from $4.4 million in Q4 2025.

Vireo Growth (VREOF) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $4.4 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $4.4 million, up 944.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (up 944.53% YoY), and the FY2025 annual result was $4.4 million, up 944.53% from the prior year.
  • Other Non-Current Assets came in at $4.4 million for Q1 2026 at Vireo Growth, roughly flat from $4.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $8.6 million in Q2 2025 to a low of $383645.0 in Q2 2023.
  • The 5-year median for Other Non-Current Assets is $593812.0 (2023), against an average of $1.9 million.
  • Across the five-year window, Other Non-Current Assets tumbled 83.41% in 2023 and surged 1520.22% in 2025, its largest moves.
  • Vireo Growth's Other Non-Current Assets stood at $2.3 million in 2022, then sank by 83.41% to $383645.0 in 2023, then rose by 9.8% to $421244.0 in 2024, then surged by 944.53% to $4.4 million in 2025, then changed by 0.0% to $4.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $4.4 million (Q1 2026), $4.4 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Vireo Growth - - 59.30 Mn 4.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.40 Mn
Dec 31, 2025 4.40 Mn
Sep 30, 2025 2.13 Mn
Jun 30, 2025 8.65 Mn
Mar 31, 2025 421,244.00
Dec 31, 2024 421,244.00
Sep 30, 2024 533,745.00
Jun 30, 2024 533,745.00
Mar 31, 2024 533,745.00
Dec 31, 2023 383,645.00
Sep 30, 2023 383,645.00
Jun 30, 2023 383,645.00
Mar 31, 2023 593,812.00
Dec 31, 2022 2.31 Mn
Sep 30, 2022 2.18 Mn
Jun 30, 2022 2.12 Mn
Mar 31, 2022 1.99 Mn
Dec 31, 2021 1.72 Mn
Sep 30, 2021 1.34 Mn
Jun 30, 2021 1.41 Mn